Conversely, higher levels of CR1 (OR: 1.17; 95% CI, 1.08–1.27) and PARP1 (OR: 4.10; 95% CI, 1.75–9.59) were positively associated with MS risk (Table S7). This evidence concerns the gene PARP1 and myeloid sarcoma.